Antidiabetic Effects of a Tripeptide That Decreases Abundance of Na+‑d‑glucose Cotransporter SGLT1 in the Brush-Border Membrane of the Small Intestine

• Christoph Otto,
• Alexandra Friedrich,
• Ivana Vrhovac Madunić,
• Christian Baumeier,
• Robert W. Schwenk,
• Dean Karaica,
• Christoph-Thomas Germer,
• Annette Schürmann,
• Ivan Sabolić,
• Hermann Koepsell

Affiliations

Christoph Otto

Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery, University Hospital of Würzburg, Würzburg, Germany

Alexandra Friedrich

Institute of Anatomy and Cell Biology, University of Würzburg, Würzburg, Germany

Ivana Vrhovac Madunić

Molecular Toxicology Unit, Institute for Medical Research and Occupational Health, Zagreb, Croatia

Christian Baumeier

Department of Experimental Diabetology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany

Robert W. Schwenk

Department of Experimental Diabetology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany

Dean Karaica

Molecular Toxicology Unit, Institute for Medical Research and Occupational Health, Zagreb, Croatia

Christoph-Thomas Germer

Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery, University Hospital of Würzburg, Würzburg, Germany

Annette Schürmann

Department of Experimental Diabetology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany

Ivan Sabolić

Molecular Toxicology Unit, Institute for Medical Research and Occupational Health, Zagreb, Croatia

Hermann Koepsell

Institute of Anatomy and Cell Biology, University of Würzburg, Würzburg, Germany